Lisa Stockman-Mauriello is dying from ALS, but a pharmaceutical company, Biogen, is trialing a new drug called Torfersen that may buy her a little extra time.
Anyone with commercial insurance, and those without insurance at all, can continue filling their monthly prescription of Lilly insulins for $35 through this program.